Daniell Richard, EVP of Europe Commercial at TEVA Pharmaceutical Industries ($TEVA), made seven open market sales of company shares over the last year, totaling $11.0 million. His latest sale occurred on March 5, 2026. Among nearly 12,000 insiders, his sales rank 1,049th, surpassing the average of $8.6 million and 6.4 transactions per seller. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | M | Restricted Share Units | 17295 | $0.00 | 51,887.0000 | 1,163,000,000 | 25.00% | 0.00% |
| March 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | M | Ordinary Shares | 17295 | $0.00 | 103,050.0000 | 1,163,000,000 | 20.17% | 0.00% |
| March 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | S | Ordinary Shares | 17295 | $31.67 | 85,755.0000 | 1,163,000,000 | 16.78% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | M | Ordinary Shares | 33512 | $0.00 | 156,639.0000 | 1,163,000,000 | 27.22% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | S | Ordinary Shares | 33512 | $32.46 | 123,127.0000 | 1,163,000,000 | 21.39% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | M | Ordinary Shares | 20461 | $0.00 | 143,588.0000 | 1,163,000,000 | 16.62% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | S | Ordinary Shares | 20461 | $32.46 | 123,127.0000 | 1,163,000,000 | 14.25% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | M | Restricted Share Units | 33512 | $0.00 | 0.0000 | 1,163,000,000 | 100.00% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | S | Ordinary Shares | 37372 | $32.95 | 85,755.0000 | 1,163,000,000 | 30.35% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | M | Restricted Share Units | 20461 | $0.00 | 40,923.0000 | 1,163,000,000 | 33.33% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | A | Restricted Share Units | 33424 | $0.00 | 33,424.0000 | 1,163,000,000 | 9999.99% | 0.00% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | M | Restricted Share Units | 141478 | $0.00 | 0.0000 | 1,163,000,000 | 100.00% | 0.01% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | M | Restricted Share Units | 62250 | $0.00 | 62,253.0000 | 1,163,000,000 | 50.00% | 0.01% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | S | Ordinary Shares | 66735 | $32.36 | 123,127.0000 | 1,163,000,000 | 35.15% | 0.01% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | M | Ordinary Shares | 141478 | $0.00 | 189,862.0000 | 1,163,000,000 | 292.41% | 0.01% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | S | Ordinary Shares | 62250 | $32.36 | 48,384.0000 | 1,163,000,000 | 56.27% | 0.01% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | EVP, Europe Commercial | M | Ordinary Shares | 62250 | $0.00 | 110,634.0000 | 1,163,000,000 | 128.66% | 0.01% |
| Jan. 27, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | A | Restricted Share Units | 141478 | $0.00 | 141,478.0000 | 1,163,000,000 | 9999.99% | 0.01% |
| Dec. 9, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Ordinary Shares | 100457 | $18.61 | 148,841.0000 | 1,164,000,000 | 207.62% | 0.01% |
| Dec. 9, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Ordinary Shares | 15011 | $16.99 | 163,852.0000 | 1,164,000,000 | 10.09% | 0.00% |
| Dec. 9, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 115468 | $28.68 | 48,384.0000 | 1,164,000,000 | 70.47% | 0.01% |
| Dec. 9, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Stock Options (right to buy) | 100457 | $0.00 | 0.0000 | 1,164,000,000 | 100.00% | 0.01% |
| Dec. 9, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Stock Options (right to buy) | 15011 | $0.00 | 0.0000 | 1,164,000,000 | 100.00% | 0.00% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 48385 | $15.90 | 48,384.0000 | 1,131,000,000 | 50.00% | 0.00% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Ordinary Shares | 22576 | $0.00 | 119,345.0000 | 1,131,000,000 | 23.33% | 0.00% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 22576 | $15.91 | 96,769.0000 | 1,131,000,000 | 18.92% | 0.00% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | A | Restricted Share Units | 69182 | $0.00 | 69,182.0000 | 1,131,000,000 | 9999.99% | 0.01% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Restricted Share Units | 22576 | $0.00 | 0.0000 | 1,131,000,000 | 100.00% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Restricted Share Units | 33512 | $0.00 | 33,512.0000 | 1,131,000,000 | 50.00% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Ordinary Shares | 33512 | $0.00 | 33,512.0000 | 1,131,000,000 | 9999.99% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 21870 | $15.73 | 11,641.0000 | 1,131,000,000 | 65.26% | 0.00% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 11641 | $15.91 | 0.0000 | 1,131,000,000 | 100.00% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Ordinary Shares | 20461 | $0.00 | 20,461.0000 | 1,131,000,000 | 9999.99% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 13353 | $15.73 | 7,108.0000 | 1,131,000,000 | 65.26% | 0.00% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 7108 | $15.91 | 0.0000 | 1,131,000,000 | 100.00% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Ordinary Shares | 183169 | $0.00 | 183,169.0000 | 1,131,000,000 | 9999.99% | 0.02% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 56385 | $15.73 | 126,784.0000 | 1,131,000,000 | 30.78% | 0.00% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 30015 | $15.91 | 96,769.0000 | 1,131,000,000 | 23.67% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Restricted Share Units | 20461 | $0.00 | 61,384.0000 | 1,131,000,000 | 25.00% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Restricted Share Units | 183169 | $0.00 | 0.0000 | 1,131,000,000 | 100.00% | 0.02% |
| March 3, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Ordinary Shares | 62250 | $0.00 | 62,250.0000 | 1,131,000,000 | 9999.99% | 0.01% |
| March 3, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 49314 | $16.19 | 12,936.0000 | 1,131,000,000 | 79.22% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 12936 | $15.56 | 0.0000 | 1,131,000,000 | 100.00% | 0.00% |
| March 3, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Restricted Share Units | 62250 | $0.00 | 124,503.0000 | 1,131,000,000 | 33.33% | 0.01% |
| Jan. 28, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | A | Restricted Share Units | 183169 | $0.00 | 183,169.0000 | 1,131,000,000 | 9999.99% | 0.02% |
| Aug. 12, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 98943 | $17.30 | 0.0000 | 1,133,000,000 | 100.00% | 0.01% |
| March 5, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Restricted Share Units | 55226 | $0.00 | 0.0000 | 1,119,000,000 | 100.00% | 0.00% |
| March 5, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Restricted Share Units | 22576 | $0.00 | 22,576.0000 | 1,119,000,000 | 50.00% | 0.00% |
| March 5, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 26053 | $13.52 | 98,943.0000 | 1,119,000,000 | 20.84% | 0.00% |
| March 5, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Ordinary Shares | 55226 | $0.00 | 124,996.0000 | 1,119,000,000 | 79.15% | 0.00% |
| March 5, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 22576 | $13.52 | 69,770.0000 | 1,119,000,000 | 24.45% | 0.00% |
| March 5, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Ordinary Shares | 22576 | $0.00 | 92,346.0000 | 1,119,000,000 | 32.36% | 0.00% |
| March 4, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Restricted Share Units | 33512 | $0.00 | 67,024.0000 | 1,119,000,000 | 33.33% | 0.00% |
| March 4, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | A | Restricted Share Units | 81845 | $0.00 | 81,845.0000 | 1,119,000,000 | 9999.99% | 0.01% |
| March 4, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 33512 | $13.34 | 69,770.0000 | 1,119,000,000 | 32.45% | 0.00% |
| March 4, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Ordinary Shares | 33512 | $0.00 | 103,282.0000 | 1,119,000,000 | 48.03% | 0.00% |
| March 4, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 62250 | $13.34 | 69,770.0000 | 1,119,000,000 | 47.15% | 0.01% |
| March 3, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Ordinary Shares | 62250 | $0.00 | 132,020.0000 | 1,119,000,000 | 89.22% | 0.01% |
| March 3, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Restricted Share Units | 62250 | $0.00 | 186,753.0000 | 1,119,000,000 | 25.00% | 0.01% |
| Feb. 28, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Ordinary Shares | 20599 | $0.00 | 90,369.0000 | 1,119,000,000 | 29.52% | 0.00% |
| Feb. 28, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | S | Ordinary Shares | 20599 | $13.12 | 69,770.0000 | 1,119,000,000 | 22.79% | 0.00% |
| Feb. 28, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | M | Restricted Share Units | 20599 | $0.00 | 0.0000 | 1,119,000,000 | 100.00% | 0.00% |
| Jan. 30, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Daniell Richard | Exec. VP, European Commercial | A | Restricted Share Units | 55226 | $0.00 | 55,226.0000 | 1,119,000,000 | 9999.99% | 0.00% |